Peptide Compounds for Neural Cell Differentiation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for expanding and differentiating stem cells, particularly for neurological disorders, are inefficient and lack effective protocols to produce specific cell types like neurons, despite the potential of stem cells in repairing central nervous system damages.

Innovation Solution

The use of specific peptide compounds derived from TSR patterns of SCO-spondin, which promote survival, growth, and differentiation of progenitor or stem cells by stimulating these cells through specific receptors, potentially leading to neural cell differentiation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional culture media and growth factors are used to expand stem cells, then cell multiplication is achieved, but differentiation into specific neural cell types remains inefficient

Engineering Contradiction:
Improvestem cell expansion efficiencyVSAvoidneural cell differentiation specificity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention segments the differentiation process by using distinct peptide compounds for different stages: TSR20 peptide for neural progenitor expansion and TSR21 peptide for neuronal differentiation. This segmentation allows optimization of each stage independently, achieving both high expansion efficiency and specific neural cell type production.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention changes the chemical parameters by using specific peptide sequences (TSR20 and TSR21) derived from SCO-spondin with precise amino acid compositions. These parameter changes in peptide structure enable specific receptor binding and signal transduction that directs stem cells toward neural lineages with high efficiency.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If thrombospondin-based compounds are used to modulate cellular functions, then cell adhesion and communication are improved, but controlled differentiation into specific cell types is limited

Engineering Contradiction:
Improvecell-cell interaction qualityVSAvoiddifferentiation direction control
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The invention segments the thrombospondin molecule into specific functional domains (TSR repeats 20 and 21) that can be used as independent peptide compounds. This segmentation allows each peptide to perform specific functions: TSR20 for maintaining progenitor state and TSR21 for inducing neuronal differentiation, thereby providing both reliable cell interaction and controlled differentiation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention applies local quality by using specific amino acid sequences within the thrombospondin molecule (residues 1738-1757 for TSR20 and 1784-1803 for TSR21) that have distinct biological activities. This local quality approach enables precise control over stem cell fate by selecting specific regions of the parent molecule with differentiated functions.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The peptide compounds effectively stimulate the survival, growth, and differentiation of stem cells, particularly into neural cells, as demonstrated by increased expression of neural markers and accelerated differentiation pathways, offering a promising approach for neurological repair.

Implementation Method 1

these peptides act on nerve cells through a specific receptor

Methodology Applied
Scientific EffectReceptor binding:

Data Source

PatentUS12163154B2Use of peptide compounds for promoting survival, growth and cell differentiation
Publication Date: 2024.12.10 AXOLTIS PHARMA
  • US12163154B2 patent drawing
  • US12163154B2 patent drawing
  • US12163154B2 patent drawing

AI summary

The present invention relates to the use of peptide compounds for promoting survival and/or growth and/or differentiation of progenitor cells or stem cells.